154 related articles for article (PubMed ID: 17711485)
1. Tuberculosis and Legionella pneumophila pneumonia in a patient receiving anti-tumour necrosis factor-alpha (anti-TNF-alpha) treatment.
Mancini G; Erario L; Gianfreda R; Oliva A; Massetti AP; Mastroianni CM; Vullo V
Clin Microbiol Infect; 2007 Oct; 13(10):1036-7. PubMed ID: 17711485
[No Abstract] [Full Text] [Related]
2. [Legionella pneumonia in patients treated with infliximab].
Vinter H; Nielsen HI
Ugeskr Laeger; 2009 Jan; 171(4):247. PubMed ID: 19174042
[TBL] [Abstract][Full Text] [Related]
3. Alopecia areata universalis during off-label treatment with Infliximab in a patient with Behçet disease.
Beccastrini E; Squatrito D; Emmi G; Fabbri P; Emmi L
Dermatol Online J; 2010 Sep; 16(9):15. PubMed ID: 20875336
[TBL] [Abstract][Full Text] [Related]
4. Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists.
Tubach F; Ravaud P; Salmon-Céron D; Petitpain N; Brocq O; Grados F; Guillaume JC; Leport J; Roudaut A; Solau-Gervais E; Lemann M; Mariette X; Lortholary O;
Clin Infect Dis; 2006 Nov; 43(10):e95-100. PubMed ID: 17051484
[TBL] [Abstract][Full Text] [Related]
5. First reported United States case of Legionella pneumophila serogroup 1 pneumonia in a patient receiving anti-tumor necrosis factor-alpha therapy.
Jinno S; Pulido S; Pien BC
Hawaii Med J; 2009 Jun; 68(5):109-12. PubMed ID: 19583105
[TBL] [Abstract][Full Text] [Related]
6. A case of severe MAGIC syndrome treated successfully with the tumor necrosis factor-alpha inhibitor infliximab.
Geissal ED; Wernick R
J Clin Rheumatol; 2010 Jun; 16(4):185-7. PubMed ID: 20414125
[TBL] [Abstract][Full Text] [Related]
7. Role of anti-tumour necrosis factor-alpha therapeutic agents in the emergence of infections.
Moiton MP; Richez C; Dumoulin C; Mehsen N; Dehais J; Schaeverbeke T
Clin Microbiol Infect; 2006 Dec; 12(12):1151-3. PubMed ID: 17121619
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab.
Jalili A; Kinaciyan T; Barisani T; Peck-Radosavljevic M; Stingl G; Geusau A; Wöhrl S
Iran J Immunol; 2009 Mar; 6(1):55-8. PubMed ID: 19293479
[No Abstract] [Full Text] [Related]
9. A severe complication of anti-TNF alfa treatment.
Fabroni C; Gori A; Prignano F; Lotti T
G Ital Dermatol Venereol; 2010 Dec; 145(6):775-7. PubMed ID: 21139554
[TBL] [Abstract][Full Text] [Related]
10. Fibrotic strictures and anti-TNF-alpha therapy in Crohn's disease.
Sorrentino D; Terrosu G; Vadalà S; Avellini C
Digestion; 2007; 75(1):22-4. PubMed ID: 17429204
[No Abstract] [Full Text] [Related]
11. De novo tuberculosis during infliximab therapy in a patient with Behçet disease.
Skvara H; Duschek N; Karlhofer F
J Dtsch Dermatol Ges; 2009 Jul; 7(7):616-9. PubMed ID: 19192011
[TBL] [Abstract][Full Text] [Related]
12. A case of legionellosis during treatment with a TNFalpha antagonist.
Wondergem MJ; Voskuyl AE; van Agtmael MA
Scand J Infect Dis; 2004; 36(4):310-1. PubMed ID: 15198192
[TBL] [Abstract][Full Text] [Related]
13. Sustained remission after infliximab in a child with vasculitis refractory to conventional immunosuppressives including interferon-alpha.
Evereklioglu C; Borlu M
Br J Ophthalmol; 2008 Aug; 92(8):1034, 1148-9. PubMed ID: 18653594
[No Abstract] [Full Text] [Related]
14. [When can TNF-alpha inhibitors against inflammatory bowel disease be withdrawn?].
Moum B
Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1673. PubMed ID: 17571118
[No Abstract] [Full Text] [Related]
15. Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.
Iwata S; Saito K; Yamaoka K; Tsujimura S; Nawata M; Suzuki K; Tanaka Y
Rheumatology (Oxford); 2009 Aug; 48(8):1012-3. PubMed ID: 19465589
[No Abstract] [Full Text] [Related]
16. Anti-TNF-alpha therapy for uveitis: Behçet and beyond.
Murray PI; Sivaraj RR
Eye (Lond); 2005 Aug; 19(8):831-3. PubMed ID: 16086039
[No Abstract] [Full Text] [Related]
17. Successful treatment of severe Behçet's disease with infliximab in an Italian Olympic athlete.
Olivieri I; Latanza L; Siringo S; Peruz G; Di Iorio V
J Rheumatol; 2008 May; 35(5):930-2. PubMed ID: 18464316
[TBL] [Abstract][Full Text] [Related]
18. What is the association between the tumor necrosis factor-alpha inhibitor infliximab and complex regional pain syndrome type I?
Paraskevas KI
Paediatr Anaesth; 2008 Jul; 18(7):689-90. PubMed ID: 18331547
[No Abstract] [Full Text] [Related]
19. A case of Legionella pneumophila pneumonia followed by invasive aspergillosis.
Saijo T; Izumikawa K; Takazono T; Kosai K; Kurihara S; Nakamura S; Imamura Y; Miyazaki T; Seki M; Kakeya H; Yamamoto Y; Yanagihara K; Miyazaki Y; Fukushima K; Kohno S
Jpn J Infect Dis; 2008 Sep; 61(5):379-81. PubMed ID: 18806346
[TBL] [Abstract][Full Text] [Related]
20. [TNF-blockade--new strategy in difficult-to-treat asthma].
Dahlén SE; Millinger E; Skedinger M; Zetterström O; Dahlén B
Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1946-8. PubMed ID: 18681378
[No Abstract] [Full Text] [Related]
[Next] [New Search]
